Cancer Genetics, Inc

(NASDAQ:CGIX)

Latest On Cancer Genetics, Inc (CGIX):

Date/Time Type Description Signal Details
2021-03-25 11:15 ESTNewsCancer Genetics stock up on shareholder approval for Stemonix dealN/A
2021-03-12 22:13 ESTNewsCancer Genetics (CGIX) Investor Presentation - SlideshowN/A
2021-02-11 04:37 ESTNewsCancer Genetics more than doubles after merger terms updateN/A
2021-02-11 04:36 ESTNewsCancer Genetics to raise $17.5M via stock offeringN/A
2021-01-29 15:38 ESTNewsCancer Genetics under pressure after $10M capital raiseN/A
2020-12-13 03:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 19:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 19:57 ESTNewsCancer Genetics reports Q3 resultsN/A
2020-11-07 15:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 17:30 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 13:57 ESTNewsCancer Genetics plummets 38% after raising 'bought deal' offering to $3MN/A
2020-09-19 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:23 ESTFinancialsCompany financials have been released.Neutral
2020-08-25 04:25 ESTNewsCancer Genetics skyrockets on acquisition of StemoniXN/A
2020-08-14 16:21 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 15:33 ESTNewsCancer Genetics reports Q2 resultsN/A
2020-07-31 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-10 08:24 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:19 ESTFinancialsCompany financials have been released.Neutral
2020-06-27 15:11 ESTNewsMixed shelf roundup - healthcareN/A
2020-06-27 00:21 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 07:57 ESTNewsCancer Genetics reports Q1 resultsN/A
2020-06-03 12:21 ESTFinancialsCompany financials have been released.Neutral
2020-06-01 21:17 ESTNewsCancer Genetics reports Q4 resultsN/A
2020-05-31 16:52 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:27 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 23:23 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:25 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:25 ESTEarningsEarnings have been released on March 23, 2017, with -$4.42 earnings per share.Sell
2020-02-21 23:19 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:21 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:21 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 03:25 ESTEarningsEarnings have been released on August 15, 2017, with -$4.85 earnings per share.Sell
2020-01-28 03:25 ESTEarningsEarnings have been released on December 31, 2018, with -$4.20 earnings per share.Sell
2020-01-28 03:25 ESTEarningsEarnings have been released on November 20, 2018, with -$9.34 earnings per share.Sell
2020-01-28 03:25 ESTEarningsEarnings have been released on May 15, 2018, with -$4.94 earnings per share.Sell
2020-01-27 23:19 ESTFinancialsCompany financials have been released.Neutral
2020-01-15 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-12-21 23:12 ESTFinancialsCompany financials have been released.Neutral
2019-12-16 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-12-06 13:59 ESTNewsTRNX, YEXT, BIG and CGIX among midday moversN/A
2019-12-06 12:17 ESTNewsClovis Oncology among healthcare gainers; Curis among losersN/A
2019-11-29 11:37 ESTNewsX, NVAX, PIR and SVRA among midday moversN/A
2019-11-27 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-11-26 23:20 ESTFinancialsCompany financials have been released.Neutral
2019-11-22 23:18 ESTFinancialsCompany financials have been released.Neutral
2019-11-22 13:08 ESTNewsBKE, GSX, HEXO and PSTG among midday moversN/A
2019-11-22 11:08 ESTNewsEyeGate Pharmaceuticals leads healthcare gainers; HEXO and Recro Pharma among losersN/A

About Cancer Genetics, Inc (CGIX):

Cancer Genetics, Inc., through its subsidiary, vivoPharm, Pty Ltd., provides contract research services primarily focusing on studies to guide drug discovery and development programs in the oncology and immuno-oncology fields. The company's clinical offerings include a portfolio of proprietary tests, such as comparative genomic hybridization microarrays and next generation sequencing panels, gene expression tests, and DNA fluorescent in situ hybridization probes targeting hematological, and human papillomavirus-associated cancers, which include cervical, anal, head, and neck cancers. It serves the biotechnology and pharmaceutical customers in the United States, Europe, and Australia. Cancer Genetics, Inc. was founded in 1999 and is headquartered in Rutherford, New Jersey.

CGIX Quotes by TradingView

See Advanced Chart

General

  • Name Cancer Genetics, Inc
  • Symbol CGIX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 110
  • Last Split Factor1:30
  • Last Split Date2019-10-25
  • Fiscal Year EndDecember
  • IPO Date2013-04-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.cancergenetics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 2.25
  • Price/Book (Most Recent Quarter) 14.31
  • Enterprise Value Revenue 10.71
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Profit Margin -72%
  • Operating Margin -58%
  • Return on Assets -15%
  • Return on Equity -69%
  • Revenue 6.33 million
  • Earnings Per Share -$0.52
  • Revenue Per Share $2.9
  • Gross Profit 3.6 million
  • Quarterly Earnings Growth -24.2%
View More

Highlights

  • Market Capitalization 66.12 million
  • EBITDA -15285000
  • PEG Ratio -0.08
  • Analyst Target Price $3
  • Book Value Per Share $1.92
View More

Share Statistics

  • Shares Outstanding 10.56 million
  • Shares Float 3.51 million
  • % Held by Insiders 749%
  • % Held by Institutions 16.92%
  • Shares Short 494219
  • Shares Short Prior Month 1.15 million
  • Short Ratio 0.11
  • Short % of Float 5%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 2.72
  • 52 Week High $7.7
  • 52 Week Low $1.98
  • 50 Day Moving Average 5.7
  • 200 Day Moving Average 3.97
View More

Dividends

  • Dividend Date 2019-10-25
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Cancer Genetics, Inc (CGIX) Dividend Calendar:

CGIX's last dividend payment was made to shareholders on October 25, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Cancer Genetics, Inc (CGIX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$N/A-$0.58
2020-06-302020-09-30$N/A-$0.58
2020-03-312020-06-30$N/A-$0.82
2019-12-312020-03-31$1.89 million-$0.56
2019-09-302019-12-31$2.07 million$0.12
2019-06-302019-09-30$1.53 million-$2.38
2019-03-312019-06-30$1.82 million-$0.24-$4.8095.03%
2018-12-312019-03-31$6.83 million-$1.06-$4.8077.83%
2018-09-302018-11-19$5.94 million-$9.30-$5.10-82.35%
2018-06-302018-08-14$7.04 million-$3.90-$4.6516.13%
2018-03-312018-05-15$7.67 million-$4.80-$3.90-23.08%
2017-09-302017-11-09$8.03 million-$0.90-$3.8076.32%
2017-06-302017-08-14$6.6 million-$4.20-$4.506.67%
2017-03-312017-05-11$6.97 million-$15.30-$5.40-183.33%
2016-12-312017-03-23$7.23 million-$4.50-$6.4530.23%
2016-09-302016-11-09$6.75 million-$6.90-$8.2516.36%
2016-06-302016-08-09$7 million-$8.40-$9.9015.15%
2016-03-312016-05-10$6.07 million-$11.70-$12.758.24%
2015-12-312016-03-10$5.48 million-$14.10-$13.80-2.17%
2015-09-302015-11-09$4 million-$0.56-$0.49-14.29%
2015-06-302015-08-11$4.19 million-$0.51-$0.510%
2015-03-312015-05-11$4.37 million-$0.44-$0.5418.52%
2014-12-312015-03-12$4.04 million-$0.54-$0.50-8%
2014-09-302014-11-10$3.22 million-$0.51-$0.48-6.25%
2014-06-302014-08-14$1.51 million-$13.50-$11.10-21.62%
2014-03-312014-05-15$1.43 million-$8.10-$8.807.95%
2013-12-312014-03-26$1.86 million-$9.30-$10.8013.89%
2013-09-302013-11-13$1.71 million-$18.30-$21.1513.48%
2013-06-302013-08-05$1.83 million-$17.40-$15.90-9.43%
2013-03-312013-05-29$1.22 million-$9.99

Cancer Genetics, Inc (CGIX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Cancer Genetics, Inc (CGIX) Chart:

Cancer Genetics, Inc (CGIX) News:

Below you will find a list of latest news for Cancer Genetics, Inc (CGIX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Cancer Genetics, Inc (CGIX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Cancer Genetics, Inc (CGIX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1349929/000149315220011939/0001493152-20-011939-index.htm
2020-07-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1349929/000000000020006001/0000000000-20-006001-index.htm
2019-02-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000088430019000005/0000884300-19-000005-index.htm
2019-01-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000049/0000905718-19-000049-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000053/0000905718-19-000053-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000055/0000905718-19-000055-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000057/0000905718-19-000057-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000094/0000905718-19-000094-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000095/0000905718-19-000095-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000096/0000905718-19-000096-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000097/0000905718-19-000097-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000555/0000905718-19-000555-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000698/0000905718-19-000698-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000700/0000905718-19-000700-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000702/0000905718-19-000702-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000704/0000905718-19-000704-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000090571819000723/0000905718-19-000723-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000093583619000102/0000935836-19-000102-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000103738920000010/0001037389-20-000010-index.htm
2018-07-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000114036118033906/0001140361-18-033906-index.htm
2020-10-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000121390020034105/0001213900-20-034105-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992918000012/0001349929-18-000012-index.htm
2018-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992918000014/0001349929-18-000014-index.htm
2019-04-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1349929/000134992919000003/0001349929-19-000003-index.htm
2019-05-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992919000005/0001349929-19-000005-index.htm
2019-07-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000134992919000008/0001349929-19-000008-index.htm
2019-08-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992919000010/0001349929-19-000010-index.htm
2019-11-1910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992919000013/0001349929-19-000013-index.htm
2020-05-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1349929/000134992920000005/0001349929-20-000005-index.htm
2020-06-2410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992920000008/0001349929-20-000008-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000134992920000013/0001349929-20-000013-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218011259/0001493152-18-011259-index.htm
2018-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218011514/0001493152-18-011514-index.htm
2018-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218011609/0001493152-18-011609-index.htm
2018-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218012409/0001493152-18-012409-index.htm
2018-09-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218013540/0001493152-18-013540-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218013580/0001493152-18-013580-index.htm
2018-09-21425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218013581/0001493152-18-013581-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218014232/0001493152-18-014232-index.htm
2018-10-09425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218014233/0001493152-18-014233-index.htm
2018-10-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218014555/0001493152-18-014555-index.htm
2018-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218014556/0001493152-18-014556-index.htm
2018-10-18425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218014635/0001493152-18-014635-index.htm
2018-11-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016096/0001493152-18-016096-index.htm
2018-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016154/0001493152-18-016154-index.htm
2018-11-14425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016160/0001493152-18-016160-index.htm
2018-11-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016356/0001493152-18-016356-index.htm
2018-11-16425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016357/0001493152-18-016357-index.htm
2018-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016501/0001493152-18-016501-index.htm
2018-11-19425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016505/0001493152-18-016505-index.htm
2018-11-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016636/0001493152-18-016636-index.htm
2018-11-21425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218016637/0001493152-18-016637-index.htm
2018-12-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000149315218017147/0001493152-18-017147-index.htm
2018-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218017571/0001493152-18-017571-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315218017847/0001493152-18-017847-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219000235/0001493152-19-000235-index.htm
2019-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219000351/0001493152-19-000351-index.htm
2019-01-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315219000364/0001493152-19-000364-index.htm
2019-01-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315219000429/0001493152-19-000429-index.htm
2019-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219000430/0001493152-19-000430-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219000686/0001493152-19-000686-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219000715/0001493152-19-000715-index.htm
2019-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315219001022/0001493152-19-001022-index.htm
2019-01-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315219001121/0001493152-19-001121-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219001122/0001493152-19-001122-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219001246/0001493152-19-001246-index.htm
2019-02-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219002205/0001493152-19-002205-index.htm
2019-04-01NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1349929/000149315219004562/0001493152-19-004562-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219005013/0001493152-19-005013-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219005384/0001493152-19-005384-index.htm
2019-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1349929/000149315219005670/0001493152-19-005670-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219006084/0001493152-19-006084-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1349929/000149315219006090/0001493152-19-006090-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219006616/0001493152-19-006616-index.htm
2019-05-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1349929/000149315219007590/0001493152-19-007590-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219007930/0001493152-19-007930-index.htm
2019-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219008530/0001493152-19-008530-index.htm
2019-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219009438/0001493152-19-009438-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219010411/0001493152-19-010411-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219010893/0001493152-19-010893-index.htm
2019-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219010896/0001493152-19-010896-index.htm
2019-07-258-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219011078/0001493152-19-011078-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219012198/0001493152-19-012198-index.htm
2019-08-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1349929/000149315219012516/0001493152-19-012516-index.htm
2019-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219013113/0001493152-19-013113-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219015939/0001493152-19-015939-index.htm
2019-10-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219015950/0001493152-19-015950-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219017035/0001493152-19-017035-index.htm
2019-11-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1349929/000149315219017462/0001493152-19-017462-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315219018090/0001493152-19-018090-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220002763/0001493152-20-002763-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220003049/0001493152-20-003049-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220005198/0001493152-20-005198-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220007255/0001493152-20-007255-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220007256/0001493152-20-007256-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220008767/0001493152-20-008767-index.htm
2020-05-14NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1349929/000149315220008768/0001493152-20-008768-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220010213/0001493152-20-010213-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220011049/0001493152-20-011049-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220011735/0001493152-20-011735-index.htm
2020-06-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1349929/000149315220011939/0001493152-20-011939-index.htm
2020-07-0610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1349929/000149315220012592/0001493152-20-012592-index.htm
2020-07-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1349929/000149315220013611/0001493152-20-013611-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220015667/0001493152-20-015667-index.htm
2020-08-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220016574/0001493152-20-016574-index.htm
2020-08-24425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220016575/0001493152-20-016575-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220017193/0001493152-20-017193-index.htm
2020-09-03425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220017194/0001493152-20-017194-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220017830/0001493152-20-017830-index.htm
2020-09-15425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220017831/0001493152-20-017831-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220018261/0001493152-20-018261-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220018620/0001493152-20-018620-index.htm
2020-10-16S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220019539/0001493152-20-019539-index.htm
2020-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220019597/0001493152-20-019597-index.htm
2020-10-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315220020062/0001493152-20-020062-index.htm
2020-10-29FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220020080/0001493152-20-020080-index.htm
2020-10-29FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220020086/0001493152-20-020086-index.htm
2020-10-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1349929/000149315220020147/0001493152-20-020147-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1349929/000149315220020331/0001493152-20-020331-index.htm
2020-11-02425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1349929/000149315220020332/0001493152-20-020332-index.htm
2019-01-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000153561019000051/0001535610-19-000051-index.htm
2020-01-02SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000153561020000002/0001535610-20-000002-index.htm
2020-11-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1349929/000175392620000345/0001753926-20-000345-index.htm
2020-07-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1349929/999999999520001874/9999999995-20-001874-index.htm

Cancer Genetics, Inc (CGIX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cancer Genetics, Inc (CGIX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 749%
Institutional Ownership: 1692%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-01-14JOHN A ROBERTSChief Executive OfficerBuy100,000.000.2322,500.00112,200.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000053/0000905718-19-000053-index.htm
2019-01-14Geoffrey E. HarrisDirectorBuy100,000.000.2322,500.00127,500.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000057/0000905718-19-000057-index.htm
2019-01-31Michael Glenn MilesChief Financial OfficerBuy150,000.000.2334,500.00150,000.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000096/0000905718-19-000096-index.htm
2019-01-31JOHN A ROBERTSChief Executive OfficerBuy185,436.000.2342,650.28297,636.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000097/0000905718-19-000097-index.htm
2019-01-14JOHN PAPPAJOHNDirectorBuy1,000,000.000.23225,000.003,781,204.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000055/0000905718-19-000055-index.htm
2019-01-31JOHN PAPPAJOHNDirectorBuy1,000,000.000.23230,000.004,781,204.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000094/0000905718-19-000094-index.htm
2019-01-31Edmund CannonDirectorBuy43,479.000.2310,000.1761,873.00https://www.sec.gov/Archives/edgar/data/1349929/000090571819000095/0000905718-19-000095-index.htm